• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中枢性尿崩症患者中去氨基-8-D-精氨酸加压素(DDAVP)的药代动力学

Pharmacokinetics of 1-desamino-8-D-arginine vasopressin (DDAVP) in patients with central diabetes insipidus.

作者信息

Pullan P T, Burger H G, Johnston C I

出版信息

Clin Endocrinol (Oxf). 1978 Sep;9(3):273-8. doi: 10.1111/j.1365-2265.1978.tb02210.x.

DOI:10.1111/j.1365-2265.1978.tb02210.x
PMID:709897
Abstract

The pharmacokinetic parameters and biological duration of action of DDAVP were measured in five patients with central diabetes insipidus of differing severity. Plasma half-life correlated significantly with the duration of action (r = 0.89, P less than 0.05), 0ut there was no correlation between the severity of diabetes insipidus and either plasma half-life or duration of action of DDAVP.

摘要

在五名不同严重程度的中枢性尿崩症患者中测量了去氨加压素的药代动力学参数和生物学作用持续时间。血浆半衰期与作用持续时间显著相关(r = 0.89,P < 0.05),但尿崩症的严重程度与去氨加压素的血浆半衰期或作用持续时间之间均无相关性。

相似文献

1
Pharmacokinetics of 1-desamino-8-D-arginine vasopressin (DDAVP) in patients with central diabetes insipidus.中枢性尿崩症患者中去氨基-8-D-精氨酸加压素(DDAVP)的药代动力学
Clin Endocrinol (Oxf). 1978 Sep;9(3):273-8. doi: 10.1111/j.1365-2265.1978.tb02210.x.
2
Biological half-lives and organ distribution of tritiated 8-lysine-vasopressin and 1-deamino-8-D-arginine-vasopressin in Brattleboro rats.氚标记的8-赖氨酸加压素和1-去氨基-8-D-精氨酸加压素在布拉特洛维大鼠体内的生物半衰期及器官分布
Ann N Y Acad Sci. 1982;394:116-27. doi: 10.1111/j.1749-6632.1982.tb37417.x.
3
DDAVP (1-desamino-8-D-arginine vasopressin) clearance rate.去氨加压素(1-去氨基-8-D-精氨酸加压素)清除率。
Acta Endocrinol (Copenh). 1984 Oct;107(2):204-6. doi: 10.1530/acta.0.1070204.
4
DDAVP (1-desamino-8-D-arginine-vasopressin) treatment of central diabetes insipidus--mechanism of prolonged antidiuresis.去氨加压素(1-去氨基-8-D-精氨酸血管加压素)治疗中枢性尿崩症——持久抗利尿作用的机制
J Clin Endocrinol Metab. 1978 Mar;46(3):381-8. doi: 10.1210/jcem-46-3-381.
5
Prolonged antidiuresis by 1-desamino-8-D-arginine vasopressin (DDAVP): correlation to its plasma levels and nephrogenous cyclic AMP production.
Endocrinol Jpn. 1980 Jun;27(3):363-70. doi: 10.1507/endocrj1954.27.363.
6
Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-D-arginine vasopressin. 1. Studies in adults and children.
J Clin Endocrinol Metab. 1986 Jul;63(1):129-32. doi: 10.1210/jcem-63-1-129.
7
Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.先天性肾性尿崩症患者对1-去氨基[8-D-精氨酸]血管加压素的血流动力学和凝血反应。
N Engl J Med. 1988 Apr 7;318(14):881-7. doi: 10.1056/NEJM198804073181403.
8
Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.去氨基 - 8 - D - 精氨酸加压素对遗传性尿崩症大鼠肾前列腺素合成的剂量依赖性刺激作用。
J Pharmacol Exp Ther. 1981 Apr;217(1):87-91.
9
Vasopressin analog DDAVP in the treatment of diabetes insipidus.
Am J Dis Child. 1976 Feb;130(2):166-9. doi: 10.1001/archpedi.1976.02120030056010.
10
Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin.
Acta Endocrinol (Copenh). 1987 Jul;115(3):307-12.

引用本文的文献

1
Pharmacokinetics and haematological effects of desmopressin.
Eur J Clin Pharmacol. 1988;35(3):281-5. doi: 10.1007/BF00558266.